Caspex Marks a New Series of Opportunities for Genomics
Fusion of CRISPR and APEX2 Stands to Bolster Genome Mapping Capabilities
Supplement: CRISPR Shakes Up Tools and Tech
Innovators Are Developing More Precise DNA-Cutting and Single-Cell-Seeding Platforms
The Scoop: CRISPR Patent Case Argued Before Appeals Court
Final Verdict Could Impact Future Research and Funding
HPLC Summit Offers Expansive Biomolecular Views
High-Performance Liquid Chromatography (HPLC) Never Plateaus
For full access to this article login to GEN Select now.
Targeting Progenitor Cells to Regenerate Damaged Tissue
Progenitor Cells Studies May Show the Path toward Curing Chronic Diseases
- The promise of cell therapy for regenerative medicine is often viewed as being synonymous with stem cell therapy, but some companies are instead successfully bringing progenitor cell-based cell therapy approaches through preclinical and clinical development. They are targeting disorders that include type 1 diabetes, hearing loss, Duchenne muscular dystrophy ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.